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In mammals, the olfactory epithelium (OE) is one of the few known sites where neurons 
are continually made throughout the lifetime of the animal. An in-depth understanding of 
the mechanisms that facilitate this process could lead to important breakthroughs in the 
treatment of neurological and psychiatric diseases. At present, neither the identity of the 
stem cell responsible for this neurogenic capacity nor the mechanisms that lead to their 
activation is completely understood. In this thesis, I employ novel strategies to 
conditionally interfere with TGFβ signaling, a known modulator of neurogenesis during 
development, allowing this pathway to be inhibited in the adult OE for the first time. We 
show that expressing high levels of the TGFβ inhibitor follistatin does not appear to alter 
neurogenesis in the adult OE. I concurrently utilized a genetic fate-mapping strategy to 
examine the dynamics of Mash1-expressing cells. We found that labeling of Mash1-
expressing cells postnatally marked a population of transient amplifying cells that 
produces predominantly neurons. Unilateral lesioning of postnatally-labeled mice leads to 
the extinction of labeled cells on the lesioned side. In contrast, when labeled in utero, 
Mash1-expressing cells give rise to a variety of cell types that resemble sustentacular and 
horizontal basal cells. Together, these experiments support the hypothesis that the 
mechanisms involved in regulating development of the OE may be distinct from those 
that maintain it thoroughout life.  
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Chapter I: Introduction to Olfactory Neurogenesis 
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In medicine, our knowledge of disease and its treatment has been greatly 
enhanced by our understanding of human biology at the cellular and molecular level. 
Rational and evidence-based therapies are developed as our knowledge of these processes 
are discovered. The complex nature of the brain has hampered the mechanistic 
understanding of neurological and psychiatric disease. Model systems have proven useful 
in unraveling the underlying cellular and molecular processes leading to normal 
development and disease. The mammalian olfactory epithelium (OE) is an ideal model 
system to understand the basic process of cell fate determination and neuroregeneration. 
It has a simple architecture, with only two mature cell types, a glial and neuronal cell 
type. Additionally, these olfactory sensory neurons (OSNs) make direct connections to 
the brain, are capable of regeneration, and are readily accessible for sampling. Leading 
hypotheses regarding the genesis of psychiatric diseases such as schizophrenia postulate a 
defect in neurodevelopmental programs as the primary dysfunction. Given the continual 
regeneration of the OE, it has been targeted as a tissue that can provide a snapshot into 
neurodevelopment in adults.  The observation that CNS diseases, such as Alzheimer’s 
Disease, can also cause OSN pathology (Talamo, et al. 1989) strengthens the hope that 
understanding how they regenerate can lead to novel therapeutic modalities for brain 
diseases. However, it is unclear whether the mechanisms that underlie regeneration are 
the same as those utilized during development. Some advances have been made into 
understanding the signaling pathways that influence neurogenesis in the developing OE 
and the developmental pathways taken by progenitor cells.  This work utilized novel 
techniques to study these same pathways in the adult to determine whether the same 
mechanisms are utilized. 
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Organization of the mammalian olfactory system 
 
Olfaction is an important, ancient sense. Chemical detection allows organisms to navigate 
their environment, find food, avoid danger, and select mates. This critical ability is 
preserved across the spectrum of organisms, underlying the simple chemotaxis of bacteria 
(Wadhams and Armitage 2004). In mammals, the detection of volatile chemicals takes 
place in the olfactory epithelium (OE) (Figure 1.1a), a pseudostratified neuroepithelium 
found within the dorsal nasal cavity. In mice, this epithelium is highly turbinated, 
providing an extensive surface area for chemical detection. Odorants from the 
environment bind to olfactory receptors (ORs) located on specialized bipolar-shaped 
olfactory sensory neurons (OSNs). Adult mice have hundreds of millions of OSNs, each 
of which expresses only one of the ~1300 members of the OR superfamily (Reed, et al. 
1992). While the process of OR choice is still incompletely understood, it is clear that 
only a single allele of the gene is activated (Chess, et al. 1994), and the activation of a 
functional OR is necessary and sufficient to inhibit the further activation of OR genes 
(Lewcock and Reed 2004).  
 By the close of the 19th century, His and Ramon y Cajal had independently 
demonstrated that OSN axons project directly into the forebrain (Crews and Hunter 
1994). Binding of odorants to receptors leads to propagation of action potentials down 
these axons to the olfactory bulb (OB), where they synapse on second order neurons 
(mitral and tufted cells) and interneurons (periglomerular cells) (Shepherd 1972) (Figure 
1.1b).  Processing of odorant stimuli in the OB is aided by the topographic mapping 
inherent to the glomerular arrangement of synapses. Each glomerulus receives inputs 
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from OSNs expressing a single type of receptor.  (Mombaerts, et al. 1996). The overall 
arrangement of OR expression in the epithelium derives in part from the zonal restriction 
of receptor expression. The OE is divided roughly into 4 zones in the dorsal-ventral 
plane, and a particular receptor is expressed in only 1 of the 4 zones (though expression 
within that zone is apparently random) (Mori, et al. 2000) (Figure 1.2). Signals are 
processed and refined in the bulb before being relayed to areas of cortex, which include 
the anterior olfactory nucleus, piriform cortex, anterior cortical nucleus of the amygdala, 
periamygdaloid cortex , and the entorhinal cortex (Kosaka and Kosaka 2005). The heavy 
connections to limbic areas likely underlie the strong emotions conveyed by olfaction and 
its capacity for generating powerful memories. 
 
Cellular and Molecular Functioning of OE 
The mature OE is a psudostratified epithelium composed primarily of a glial-like cell, a 
mature neuronal cell, basal cells, and Bowman’s glands (Figure 1.3a). The sustentacular 
(sus) cells are a glial cell type that occupy the apical-most layer of the epithelium and 
send foot processes to the basement membrane (Klein and Graziadei 1983). The 
microvillar processes on their apical surfaces distinguishes them morphologically. They 
also express specific sets of genes, including cytokeratins (Pixley 1992), the transcription 
factor sox2 (Guo, et al. 2010), as well as cytochrome P450 proteins such as cyp2g1, 
presumably to help them serve in a neuroprotective role by neutralizing toxic substances 
(Gu, et al. 1999).  Sus cells are capable of self-renewal (Mackay-Sim and Kittel 1991), 
but it is unclear whether this capacity is sufficient for them to maintain their abundance 
during normal cellular turnover.  
 5 
The other mature cell type is the OSN, identifiable by its expression of neuronal 
markers including NCAM, as well as the OSN-specific proteins, olfactory marker protein 
(OMP) and the proteins involved in odorant-induced signal transduction. The cell bodies 
of these OSNs occupy the neuronal zone of the OE. These neurons send a single dendrite 
apically, with an elaborate array of cilia present above the sus cell layer, where ORs are 
found and odorant binding takes place, just a few microns below the surface of the air-
mucus interface (Menco 1980). Odorant binding leads to signal transduction mediated by 
an olfactory-specific G protein cascade, which leads to the firing of action potentials in 
the odorant-stimulated OSN (Reed, et al. 1992).  
In the basal zone of the OE, two distinct basal cell populations exist. Lining the 
basal lamina is a keratin-expressing (Suzuki and Takeda 1991), morphologically flat cell 
type known as horizontal basal cells (HBCs). This rarely-dividing cell type is capable of 
proliferating and differentiating into all OE cell types when isolated in vitro (Carter, et al. 
2004) or after severe chemical lesion of OE (Leung, et al. 2007). HBCs express the p53 
tumor suppressor-related protein p63, the expression of which appears to be necessary for 
HBC formation and prevents differentiation of HBCs (Fletcher, et al. 2011; Packard, et 
al. 2011). The p63 protein expression is downregulated when HBCs are activated to heal 
OE wounds after chemical lesion (Packard, et al. 2011). Found just apical to the HBCs 
are the globose basal cells (GBCs), a heterogeneous population of keratin-negative cells 
that is mitotically active, and capable of producing all mature cell types in the OE 
(Caggiano, et al. 1994; Schwob, et al. 1994). A subset of these cells express Sox2, and 
appear to go on to produce sus cells, while GBCs expressing mammalian achaete-scute 
homologue-1 (Mash1) predominantly produce OSNs. Cells expressing both Sox2 and 
 6 
Mash1 can be found, likely representing a common progenitor of these two pathways 
(Gokoffski, et al. 2011) (Figure 1.3b). GBCs sequentially express Mash1 and 
neurogenin1 (Ngn1) along their developmental path to producing neurons (Cau, et al. 
2002; Cau, et al. 1997). As they differentiate into neurons, they express GAP43 and begin 
to sprout dendritic and axonal processes.  Productive binding of O/E transcription factors 
to their binding sites on mature OSN protein promoters leads to the transcription of 
mature OSN genes including ACIII, Golf, OcNC, OMP, and an OR, which are associated 
with differentiation into OSNs (Wang and Reed 1993; Wang, et al. 1993; Wang, et al. 
1997). Recent work in our laboratory suggests that the zinc-finger protein OAZ may act 
as a molecular switch that enables O/E transcription factor activation (Cheng and Reed 
2007; Tsai and Reed 1997; Tsai and Reed 1998). Below the basal lamina reside the 
Bowman’s glands, whose ducts traverse the epithelium to secrete the protective mucous 
that lines the apical surface of the OE. Given the capacity for self-renewal of the OE, a 
stem cell population must exist, though it is unclear at this point whether such a cell 
resides among the HBC or GBC population (Calof, et al. 1998; Crews and Hunter 1994; 
Mackay-Sim 2010). 
 
OE development  
By mechanisms that are incompletely understood, but which likely are promoted by 
retinoic acid, fibroblast growth factor (FGF), and bone morphogenic protein (BMP) 
signaling, the olfactory placode develops from a thickening of the ectoderm at E9 
(Schlosser 2006). Continued expression of FGF appears to promote an olfactory sensory 
fate, whereas BMP signaling appears to drive the developing tissue toward a respiratory 
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fate (Maier, et al. 2010). Continued expansion of this tissue leads to invagination to form 
the olfactory pits.  Labeling for proliferating cells indicates bursts of cellular expansion, 
which can lead to bulges of epithelium up to 40 cells thick (Murdoch and Roskams 
2007). Cellular expansion is driven by the olfactory placode precursor cells (OPPs), 
which initially divide predominantly at the apical surface, but transition to the basal 
compartment around E12 (Cuschieri and Bannister 1975).  These OPPs express sox2, 
ascl1, and hes1, bearing resemblance to the GBCs of the mature OE (Packard, et al. 
2011). The development of neurons proceeds along a well-defined pathway, which is first 
established by the expression of Mash1, a neuronal-permissive transcription factor. Mice 
lacking functional Mash1 have markedly diminished neuronal generation in the OE 
(Murray, et al. 2003). Mash1 cells give rise to immediate neuronal precursors that express 
neurogenin1 (Ngn1), which give rise to GAP43-expressing immature neurons that in turn 
give rise to mature OSNs, which first appear around E12.5 (Cau, et al. 2002; Cau, et al. 
1997).  
The embryological lineage of the keratin-expressing sus cells and HBCs is less 
well established. These cell types appear to fully develop at later embryonic stages, with 
both cell types apparent by E15 (Cau, et al. 1997; Packard, et al. 2011). Recent evidence 
suggests that these cells may also be derived from the OPPs. Persistent expression of 
sox2 may lead to development into sus cells (Gokoffski, et al. 2011), whereas activation 
of p63 may lead to the development of HBCs (Packard, et al. 2011), though definitive 
lineage analysis of OPPs has yet to be performed to confirm the latter suggestion. These 
observations suggest that OPPs may serve as a common progenitor that produce all cell 
types of the OE, including both GBCs and HBCs. It is unclear whether such a multipotent 
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progenitor resides among the GBCs in the adult, or whether HBCs are the only required 
multipotent stem cell. Whatever the relationship between these cells, it is clear that 
multiple steps are involved in determining differentiation, and a number of extrinsic 
signaling pathways have been implicated in controlling these processes. 
 
Extrinsic signaling 
During embryogenesis, the growth and differentiation of various cell types and tissues are 
shaped by a vast array of cell signaling pathways, including notch, wnt, fibroblast growth 
factor (FGF), epidermal growth factor (EGF), and transforming growth factor (TGFα and 
TGFβ).  At the olfactory placode stage, FGF and EGF are important in stimulating 
neurogenesis and promote the creation and sustenance of a stem cell niche. The neural 
lineage is established by Fgf8, which is expressed highly at the rim of the invaginating pit 
(Kawauchi, et al. 2004). Once the mature OE is established, Fgf2 is important in 
maintaining the stem cell niche. EGF and TGF stimulate HBC proliferation 
(Mahanthappa and Schwarting 1993).  
 Expansion of the OE is reigned in during embryogenesis by TGFβsuperfamily 
signaling, especially members of the BMP and activin families. (Gokoffski, et al. 2011; 
Shou, et al. 1999). The ability of these molecules to inhibit neurogenesis has been well-
documented in vitro. Neurogenesis in OE primary culture is inhibited by high dose 
BMP2, BMP4, and BMP7. These molecules act specifically on the Mash1 + progenitor 
population (Shou, et al. 1999). GDF11 also inhibits neurogenesis in vitro, but acts to 
prevent INP replication (Lander, et al. 2009) Two members of the activin family, GDF11 
and Activin βB, have demonstrated the ability to inhibit neurogenesis in vivo. It is 
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believed that GDF11 acts upon immediate neuronal precursors, whereas activin βB acts 
upon a multipotent progenitor cell upstream of the INPs (Gokoffski, et al. 2011). Further, 
GDF11 knockout mice show a thickening of the OE, with overproduction of neurons and 
an expansion of the neuronal layer (Wu, et al. 2003). Conversely, knockout of follistatin 
(FST), a potent inhibitor of GDF11 and other TGFβ molecules, leads to a dramatically 
thinned OE, with negligible neurogenesis (Gokoffski, et al. 2011; Wu, et al. 2003). All of 
these findings underscore the ability of this class of molecules to regulate neurogenesis in 
the olfactory epithelium. However, despite these advances in understanding how extrinsic 
signaling pathways drive and tailor neurogenesis pathways during embryogenesis, it is 
unclear whether these same pathways are utilized during homeostasis and regeneration of 
the postnatal OE. 
 
OE Regeneration 
There is limited capacity for regeneration within the central nervous system of adult 
mammals. In most areas of the brain, destroyed neurons are not replaced, leading to 
devastating consequences following brain injury. This has led to an interest in 
understanding the mechanisms controlling neurogenesis in the few areas in which it takes 
place, for these areas contribute much to maintaining plasticity and regenerative potential 
in the CNS. These areas include the dentate gyrus of the hippocampus, the subventricular 
zone, and the olfactory epithelium. Of these areas, the olfactory epithelium has 
demonstrated the most prolific neurogenic potential. Likely due to their exposure to 
environmental insults, there is a continual proliferation of basal cells in the OE, which 
mature into OSNs (Mackay-Sim and Kittel 1991a). The lifespan of OSNs appears to be 
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limited.  While some neurons have been demonstrated to live as long as a year in mice 
living in purified air environments (Hinds, et al. 1984), labeled neurons usually do not 
survive nearly so long in the OE (Graziadei and Graziadei 1979; Mackay-Sim and Kittel 
1991b).  Some have even suggested that, given potential for infectious inoculation of the 
brain via the OE (Owen, et al. 2009), OSNs may be predisposed to apoptosis as a means 
of immunological defense (Harris, et al. 2009). Irrespective of the baseline propensity for 
apoptosis and neurogenesis, the OE has demonstrated a profound ability to regenerate 
and repopulate all cell types after various experimental lesioning paradigms.  
  Several different methodologies have been utilized to conduct lesion experiments 
of the OE, utilizing the accessible location of the OE and OB. Surgical ablation of OSN 
axons by olfactory nerve transection or olfactory bulbectomy leads to a selective loss of 
OSNs, while sparing other OE cell types (Carr and Farbman 1992; Costanzo 1985). This 
leads to an increase of basal cell proliferation, and generation of sufficient neurons to 
nearly reconstitute the OE.  In the case of olfactory nerve transection, this leads to OE 
repair, with new neurons innervating targets in the OB (Costanzo 1984).  However, 
because the synaptic target is removed during bulbectomy, full recovery is not possible 
(Gordon, et al. 1995). In fact, in mice older than 13 days, OSN axons fail to penetrate into 
the OB cavity due to the formation of glial scar tissue (Evers, et al. 1996).   
 More extensive lesions can be produced by the introduction of toxic agents to the 
apical surface of the OE, which can lead to destruction of more cell types, including sus 
cells and some basal cell populations. Under most conditions, HBCs are spared. ZnS04 
(Matulionis 1975), Triton-X-100, and MeBr gas (Schwob, et al. 1995) have all been used 
as toxic agents for this purpose. Similar effects can be obtained by the injection of the 
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anti-thyroid drug methimazole (Bergman, et al. 2002).  Even under these harsh 
conditions, the epithelium can be reconstituted to pre-lesioned status within a few weeks, 
with the recovery preserving the normal zonal expression pattern of OSNs (Iwema, et al. 
2004). For lesion experiments for which reinnervation of the olfactory bulb is possible, 
complete functional recovery appears to occur, suggesting appropriate rewiring (Harding 
and Wright 1979; Hurtt, et al. 1988; Yee and Costanzo 1995). 
 In this thesis, experiments are described that study the process of neurogenesis in 
mouse OE. By utilizing genetically-modified mice, I was able to robustly-express 
follistatin in adult mice, allowing the study of TGFβ knockdown in adult animals. 
Despite effective induction of expression, no effects on neurogenesis could be observed, 
bringing into question the importance of this signaling pathway in modulating 
neurogenesis in the adult. A separate line of investigation utilized a lineage-tracing 
paradigm to study the dynamics of GBC differentiation. Postnatal labeling of Mash1-
expressing cells marks a transient amplifying cell that gives rise to neurons. These 
labeled cells do not amplify in response to olfactory bulbectomy. Conversely, labeling of 
Mash1-expressing cells in utero marks cells that differentiate into a variety of cell types, 
most notably HBCs. Together, these observations suggest that the postnatal Mash1-




Figure 1.1. Organization of the Olfactory System 
 
(A) Schematic sagittal view of the mouse olfactory system. Volatile odorants enter the 
nasal passage (NP) and interact with OSNs in the main olfactory epithelium (MOE), 
which send their axons through the olfactory nerve (ON) to the main olfactory bulb 
(MOB). Pheromone detection occurs predominantly at the vomeronasal organ (VNO), 
which sends its signals through the vomeronasal nerve (VN) to the accessory olfactory 
bulb (AOB). (DeMaria and Ngai 2010) 
 
(B) Schematic representation of the path from odorant molecule to the brain. 1. After 
entering the nasal cavity, odorants interact with odorant receptors on the cilia of OSNs, 
located in the olfactory epithelium. 2. Odorant binding leads to the propagation of action 























Figure 1.2 Zonal expression of olfactory receptors 
The expression pattern of any given OR is restricted to a particular domain along the 
dorsal-ventral axis of the olfactory epithelium. This arrangement is carried into the bulb, 
where the OSN axons converge into glomeruli that are in a similar dorsal to ventral 




Figure 1.3 Cellular components of the olfactory epithelium 
(A) Schematic representation of OE cell types. At the apical surface of the epthelium, the 
sustentacular cells are found (yellow). These cells extend foot processes that span the 
epithelium and contact the basal lamina. Just below the sustentacular cells are the OMP-
expressing mature OSNs (purple), which send an apical dendrite above the sus cells, and 
elaborate cilia above the epithelium in the nasal mucus. OSNs span the neuronal layer. 
Within this layer are also found GAP43-expressing immature neurons (light blue). Below 
the neuronal layer is the basal layer, which is home to two cell types. The HBCs (green) 
are flat, keratin-expressing cells found at the most basal extreme of the OE, adherent to 
the basal lamina. Just above the HBCs are GBCs (dark blue), a heterogeneous population 
of round cells. These cells may express Mash1, Sox2, or a combination of both. (Duggan 
and Ngai 2007) 
 
(B) Schematic diagram demonstrating the Differentiation Pathways of OPPs. During 
embryogenesis, a population of cells exists that resembles adult GBCs. A subpopulation 
of these cells co-express Mash1 and Sox2. Expression of Mash1 is permissive for these 
cells to differentiate along the neuronal lineage, producing OSNs after a brief period of 
transient amplification. Recent evidence suggests that persistent expression of Sox2, may 















Animals are complex organisms comprised of many trillions of cells. In adults, the 
majority of these cells are highly specialized and terminally differentiated. These 
differentiated cells have exited the cell cycle, and developed specialized morphologies to 
carry out their function through unique profiles of gene expression. Before tissues arrive 
at this state – during embryogenesis – there are abundant actively dividing progenitor cell 
populations that must differentiate to form the mature cell types of the tissue. Given the 
high fidelity with which cell types and tissues are produced across organisms within a 
species, it is clear that this is a highly regulated process in which many different signaling 
pathways and transcription factors play an important role. 
One class of molecules, the TGFβ family, has been identified as a negative 
regulator of tissue growth (Massague and Gomis 2006). Mature muscle cells secrete 
myostatin, a member of this family, to inhibit proliferation of immature muscle cells, 
allowing the tissue to achieve its normal size (Lee and McPherron 1999; McPherron, et 
al. 1997). GDF11, a close relative of myostatin, has been shown to provide a similar type 
of feedback in the growing embryonic OE. In particular, it has been demonstrated that 
mice lacking functional GDF11 will develop a thickened OE with an expanded neuronal 
layer. In contrast, knocking out follistatin, a potent inhibitor of TGFβ signaling, leads to a 
dramatically-thinned OE, with minimal neuronal development. (Gokoffski, et al. 2011; 
Wu, et al. 2003). 
The olfactory epithelium is in direct contact with the external environment, and 
consequently is continually exposed to injury. As a consequence, OSNs die and are 
replaced throughout life. Given its role in fine-tuning the regenerative process during 
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embryogenesis, it is logical to suppose the TGFβ family may play a similar role in the 
adult. However, experiments that utilized a germline knockout of the GDF11 gene  could 
not examine the role of this factor in adult tissue since these animals do not survive past 
the neonatal period. We sought to investigate the role of this family of molecules in 
regulating neurogenesis in the adult by utilizing strategies to manipulate this signaling 
pathway exclusively in the olfactory epithelium, preventing the lethality associated with 
abolishing TGFβ signaling in other tissues. Conditional knockdown strategies were 
employed, utilizing Cre/Lox technology. Additionally, genetically-modified mice were 
developed to express TGFβ molecules or a selective inhibitor of this signaling pathway. 
We were able to temporally induce high levels of the TGFβ inhibitor folllistatin within 
the olfactory epithelium. Prolonged exposure to this inhibitory molecule did not produce 
noticeable effects on the olfactory epithelium, raising doubts that this system retains its 




Mouse lines, genotyping, and TRE induction 
TRE-Follistatin, TRE-Myostatin, GDF11 flox, and GDF11null mice were kindly 
provided by Dr. Se-Jin Lee. OMP-Cre mice were obtained from Dr. Peter Mombaerts. 
Cyp2g1-rtTA mice were provided by Dr. Andrew Lane. Genotyping strategy for 
GDF11flox and GDF11 null mice is provided in Figure 2.1a. OMP-Cre mice were 
genotyped by PCR amplification of the Cre-recombinase gene product, utilizing the 
following primers: forward primer: 5' - AACATGCTTCATCGTCGGTCCGGGCTGC -
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3', reverse primer, 5' - GACGGAAATCCATCGCTCGACCAGTTTA - 3'. TRE-
Follistatin and TRE-Myostatin mice were genotyped by PCR amplification of the SV40 
region of the construct utilized to generate the mice. The genotyping primers utilized 
were: forward primer, 5’- TTGCCTCCTGCTGCTGCTGC-3’, reverse primer, 5'- 
TTTTTCCCAGGTCCACAGTCCACG-3'. Cyp2g1-rtTA mice were genotyped by PCR 
amplification of the rtTA gene, utilizing the following primers: 5’- 
AACCCGTAAACTCGCCCAGAAG-3’, reverse primer, 5’- CGCAACC 
TAAAGTAAAATGCCCC-3’. For induction of TRE genes, mice were fed a grain-based 
diet with Doxycycline added (2gm/kg, Bio-Serve) for at least 30 days unless otherwise 
specified.  
 
BrdU Injection and Tissue Preparation 
Where indicated, mice were injected intraperitoneally with 0.5 mg bromodeoxyuridine 
(BrdU) (Sigma, St. Louis, MO) per 10g body weight 4 hours before sacrifice. Mice were 
deeply anesthetized with xylaket (Sigma, St. Louis, MO), and perfused with ice cold 4% 
PFA in PBS. Heads were prepared as previously described (Lewcock and Reed 2004), 
and post-fixed in 4%PFA for 30 min – overnight at 4 °C. Heads were switched to a 
solution of 30% sucrose, 250mM EDTA in PBS and incubated at 4 °C for 24hr – 72 hr. 
Heads were flash frozen in O.C.T. (Tissue-Tek, Torrance, CA) over dry ice or liquid 
nitrogen, and stored at -80 °C before sectioning. Tissue sections were cut at 8 – 20 µm 




In Situ Hybridization, Immunohistochemistry, and microscopy 
In situ hybridization was performed as previously described (Wang, et al. 2004), utilizing 
the following RNA probes: hFollistatin (nucleotide 1-1034 of NM_013409), GDF11 
(nucleotide 341 -736 of NM_10272.1), GAP43 (nucleotide 147 to 806 of NM_030553) 
and OMP (partial cDNA of NM_011010). For immunohistochemistry, the following 
primary antibodies were utilized: rabbit anti-hFollistatin (1:1000, NIDDK National 
Hormone and Peptide Program), and rat anti-BrdU (1:200, Abcam).  Slides stained with 
anti-BrdU were treated with 3N HCl for 30 min before incubation with primary antibody.  
Fluorescent visualization of primary antibody was accomplished utilizing the following 
secondary antibodies: Alexa-488 or Alexa-546-conjugated species-specific IgG. 
Chromogenic visualization of primary antibodies was accompished using horseradish 
peroxidase (HRP)-conjugated species-specific IgG (Vector Laboratories, Burlingame, 
CA)  developed with the diaminobenzadine (DAB) substrate (Sigma, St. Louis, MO). 
Images were captured with a LSM510 confocal microscope or Zeiss Axioplan.  
 
RNA isolation and realtime-PCR 
Mice were euthanized with carbon dioxide, and olfactory tissue was harvested and 
ground in ice cold Trizol (Invitrogen) in a Potter-Elvehjem tissue grinder. RNA was 
extracted according to Invitrogen’s Trizol protocol. 1 ug of resuspended RNA was treated 
with DNase, and reverse transcribed using Superscript II reverse transcriptase 
(Invitrogen) according to the Invitrogen protocol. Oligo dT primers were used to prime 
the reaction. Real time PCR was performed on an Applied Biosystems Step One Real-
Time PCR machine utilizing the following primers: GDF11: forward primer, 5' -
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CCACAGAGCAACTGGGGAATCG - 3', reverse primer, 5' - 
TATCGGCAGCAGCGGGACTCA  - 3', FST: forward primer, 5’- 
TTGCCTCCTGCTGCTGCTGC-3’, reverse primer, 5’-CTCCTTGCTCAGTTCGG 
TCTTG-3’, OMP: forward primer, 5'- AGCCCGCTGTGACCTTAGG-3', reverse primer, 
5'-GATCAAGCCCCGCTGTCAT-3'. Mash1: forward primer, 5'-
TTTGGAAGCAGGATGGCAGCAG-3', reverse primer, 5'- 
TTTCTGCCTCCCCATTTGA-3'. Ngn1: forward primer, 5'-CAATACAATGGCAAGG 
CTTAAAAA-3', reverse primer, 5'-TCGGGATCCATAATGCATGA-3'. Data is 






A Conditional Approach to GDF11 knock-down in mouse OE 
The role of TGFβ signaling in modulating neurogenesis in mouse OE has thus far been 
studied primarily in the embryo. The role played in modulating neurogenesis has been 
demonstrated for activin βB and GDF11 utilizing gene knockdown strategies in mice 
(Gokoffski, et al. 2011; Wu, et al. 2003). However, these mice do not survive postnatally 
due to extra-olfactory manifestations of TGFβ knockdown, hampering the study of this 
system in adult mice. To circumvent these difficulties, we developed a strategy utilizing 
the Cre/LoxP system to conditionally knockdown GDF11 signaling in the olfactory 
epithelium. Given that GDF11 has been suggested to be produced predominantly by 
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OSNs (Wu, et al. 2003), we utilized previously developed mice expressing Cre 
recombinase from the endogenous OMP locus. Given the high efficiency of activation of 
the OMP-cre locus (Li, et al. 2004), GDF11 expression could be eliminated in mature 
OSNs with loxP sites inserted at both GDF11 alleles (Figure 2.1a). To determine the 
efficacy of gene knockdown in the OE, real time RT-PCR was performed on RNA 
isolated from whole preparations of OE from adult GDF11flox/flox ; OMP-Cre mice. No 
reduction of RNA message levels was found in conditional knockdown mice when 
compared with littermate control GDF11 flox/flox mice lacking the OMP-Cre allele (1.1 
+/- 0.46 vs 1.2 +/- 0.24, respectively) (Figure 2.1b).  
It is possible that expression of GDF11 remained high across the OE due to 
ineffective recombination of the GDF11 flox allele. To address this, we examined GDF11 
expression levels in mice heterozygous at the GDF11 allele with GDF11flox/null. The 
GDF11 null allele has been previously demonstrated to not produce functional GDF11 
protein, and is neonatal-lethal in the homozygous state. With this strategy, only a single 
recombination event is needed in each neuron to knock out GDF11 expression. However, 
these mice also demonstrated similarly normal levels of GDF11 expression (data not 
shown.) 
Real-time PCR is useful for detecting global levels of expression across a tissue. 
In order to determine whether expression of GDF11 was reduced in discrete areas or cell 
types within the OE, we performed in situ hybridization to detect GDF11 message on 
coronal tissue sections. This methodology also failed to reveal a difference in expression 
between the GDF11 flox/flox ; OMP-Cre mice and their non-cre containing littermates. 
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(Figure 2.1c) Given that this conditional approach did not appear to achieve the desired 
result of knocking down GDF11, further analysis of these mice was not pursued. 
 
A Strategy to Inducibly Express a GDF11 analog in the OE 
 Given that germline knockdown of GDF11 leads to excessive neurogenesis and 
thickening of the OE in the embryo, overexpression of GDF11 should conversely lead to 
a decrease in neurogenesis and OE atrophy. Utilizing the tet/rtTA system, we developed a 
method to inducibly express myostatin in the mouse OE. Myostatin was substituted for 
GDF11 because the TRE-Myostatin mouse had already been generated by Dr. Se-Jin Lee, 
and the active protein formed by this construct is nearly identical to that of GDF11 
(McPherron, et al. 2009). Previous work in our laboratory demonstrated that, upon 
doxycycline administration, the cyp2g1-rtTA can cause robust activation of a transgene 
equipped with a TRE promoter in the sus cells of the OE (Figure 2.2a-b). Robust 
expression and secretion of TNF-α was observed in cyp2g1-rtTA ; TRE-TNF-α  mice 
shortly after the administration of food containing 2g/kg doxycycline. (Lane, et al. 2010). 
Secretion takes place at the foot processes, located in the basal zone of the OE. This 
location is ideal for the secretion of a TGF-β molecule presumed to inhibit neurogenesis 
through cell cycle inhibition of progenitor cells. 
To determine whether this system would produce elevated levels of myostatin in 
the mouse OE, adult mice were exposed to doxycycline in their food for > 30 days, after 
which RNA from whole OE was purified and quantified by real time RT-PCR. These 
preliminary results did not demonstrate an increase in myostatin mRNA levels compared 
to littermates lacking the TRE-myostatin construct. Since silencing of TRE-containing 
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constructs has been suggested to occur in some lines with age (Takiguchi, et al. 2013), 
the experiments were repeated with mice being started on Doxycycline as early as during 
embryonic development. Whether doxycycline exposure began at P0, P19, or E0 (i.e. 
parents were started on doxycycline before mating), no increases in myostatin message 
levels were observed in any case. Figure 2.2c shows combined real time RT-PCR results 
from these mice with littermate controls, whose expression levels were 1.2 +/- 1.0 (st. 
dev)  (n = 8) vs. 1.0 +/- 0.7 (st. dev.) (n = 4) respectively. By comparison, message levels 
in skeletal muscle were 16.9 +/- 7.0 (n =3). Given the robust activation seen with other 
TRE-driven genes in this system, such as TRE-TNFα or TRE-GFP (Lane, et al. 2010), 
this failure of expression is most likely due to silencing of the TRE transgene. Poor 
expression of this particular TRE construct had been previously observed (Se-Jin Lee, 
unpublished). Given the inability to express the TRE-myostatin gene, an alternative 
strategy was developed to alter TGFβ signaling in the adult OE. 
 
Robust Inducible-Expression of Follistatin in the OE 
Follistatin irreversibly binds and blocks activity of TGFβ family members. It is 
endogenously expressed and is believed to be important in fine-tuning TGFβ signaling in 
vivo. The importance of this molecule in this pathway is demonstrated in follistatin 
knockout mice, which demonstrate profound inhibition of neurogenesis in the OE 
(Gokoffski, et al. 2011; Wu, et al. 2003). If TGFβ signaling is equally important in 
controlling neurogenesis in the adult, inducing expression of follistatin should lead 
excessive neurogenesis and expansion of the OE. We developed a strategy to induce 
follistatin expression employing a similar strategy as had been attempted with myostatin, 
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substituting the TRE-hFollistatin transgene (Figure 2.3a-b). In contrast to the TRE-
myostatin transgene, we saw robust induction of follistatin expression in these mice after 
administration of doxycycline (dox). Before administration of dox-containing food, 
message levels of the human follistatin transgene were either undetectable or found at 
very low levels. By the third day of a dox exposure, message levels increased to 
>-50,000-X the leaky expression levels (53,800 +/- 10,100), and rose another order of 
magnitude by 30 days of constant exposure to doxycycline (426,000 +/- 236,000) (Figure 
2.3c). These day 30 levels were 10X higher than the OMP message , 9.8 +/- 5.5 vs. 1.2 
+/- 0.27 (Figure 3.1d), which is highly expressed by all mature neurons, with expression 
levels on par with those of the housekeeping gene GAPDH. 
 We next sought to examine the expression pattern of the follistatin transgene. In 
situ hybridization analysis demonstrates that follistatin is highly expressed in a subset of 
sustentacular cells (Figure 2.4a-b). It is unclear why transgene expression is non-uniform, 
but this pattern has been previously observed with this cyp2g1-rtTA construct (Lane, et 
al. 2010). The robust mRNA levels observed for the induced follistatin transgene 
suggested that elevated levels of follistatin protein would be present in the sustentacular 
cells. Antibody labeling for follistatin demonstrates that these high message levels are 
translated into protein (Figure 2.4c) and distributed within the cell in a manner consistent 
with its eventual secretion. 
 
Prolonged Exposure to Follistatin does not Affect Neurogenesis 
Knockout of follstatin in the embryo leads to a profound inhibition of neurogenesis and 
dramatic thinning of the OE (Gokoffski, et al. 2011; Wu, et al. 2003). If similar 
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mechanisms are at play in the adult OE, overexpression of follistatin should lead to an 
increase in neurogenesis, resulting in a thickening of the OE, with an expansion of the 
OSN compartment. Expansion of the neuronal population should lead to an increase in 
message level of neuronal components. We therefore performed real time RT-PCR of 
mouse OE 30 days after continuous exposure to induced follistatin expression. There 
were no observable alterations in the thickness of the OE in these mice. No change in 
expression of the mature OSN transcript OMP, GBC transcript Mash1, or immediate 
neuronal precursor transcript Ngn1 were seen when compared to mice of identical 
genotypes not exposed to doxycycline (Figure 2.5a). Given that follistatin is not 
uniformly expressed, it is possible that regional changes in neurogenesis may not be 
sufficient to alter gene expression after mRNA isolation from the crude nasal tissue. To 
test this, mice fed doxycycline for 30 days were fixed and tissue sections were assessed 
for expression levels by in situ hybridization for OMP, GAP43, and Follistatin. There 
was no observable difference in the thickness of OE, or in the expression pattern of 
GAP43 or OMP when compared to similarly-treated mice lacking the TRE-hFollistatin 
transgene.  
 One expected consequence of follistatin-induced alteration of OE dynamics is a 
modulation of proliferation of GBC progenitors.  The effects of prolonged exposure to 
follistatin on proliferation were also assessed by quantifying the number of cells that 
incorporated brdU. Mice were treated for > 30 days of doxycycline, then injected with 
brdU 4 hours before sacrifice. Staining for proliferating cells did not reveal any increase 





 TGFβ signaling has been demonstrated to be an important regulator of 
neurogenesis in the developing OE. Given the continual generation of neurons that takes 
place in the OE throughout life, it is reasonable to suppose TGFβ signaling plays a role 
there as well. Multiple strategies were employed to alter TGFβ signaling in the adult. The 
first was to employ a conditional knockout approach. Previous work had suggested that 
GDF11 was produced by OSNs. Utilizing the mature marker OMP to drive cre 
expression seemed a reasonable approach to knock down expression in an OE-specific 
manner. However, both immature and mature neurons have been implicated in the 
production of GDF11 (Wu, et al. 2003). It is possible that production in the OE was not 
diminished in the conditional knockout due to the persistent expression of GDF11 in 
other cell types, including immature neurons. 
In addition to the conditional knockdown approach, an inducible inhibitor 
approach was attempted to block TGFβ signaling in the OE. However, despite robust 
expression of FST message and protein, no effects on neurogenesis could be 
demonstrated. This could be due to a number of factors. The first possibility is that, 
despite being produced at high levels, the FST was not properly processed and delivered 
to the area of the tissue that was needed. Processing of the protein should not have been 
an issue in this case, as a variant of follistatin that was utilized that did not require 
additional steps to become active. It also seems unlikely that the follistatin was not being 
appropriately delivered. Sustentacular cells have a highly developed secretory apparatus, 
and they secrete into the basal layer of the OE at their foot processes. This is presumably 
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where much of the regulation of neurogenesis is taking place, and therefore an ideal place 
for FST to be delivered. The previous success of this sustentacular cell-specific induction 
system to direct effective production and secretion of TNF-α (Lane, et al. 2010) further 
suggests that the secretory apparatus likely did not constrain follistatin function. 
A second possible reason for the failure to discern a phenotype in the inducible 
follistatin mice is that the patchy expression pattern may have made a phenotype difficult 
to detect. Any small local effects in the number of proliferating cells or in the number of 
neurons generated may have been been obscured by the large areas that did not have 
follistatin-expressing cells in the area. An attempt was made to analyze the data taking 
this into account, but it is difficult to define the “area of influence” that could be caused 
by follistatin-secreting cells. The absence of insight into the range of diffusion or action 
of the secreted follistatin made this approach complex.  
It is also possible that the conditions that were employed were not optimized to 
reveal a phenotype. Our experimental designs were based on the hypothesis that 
prolonged exposure to TGFβ inhibitor would be most likely to disrupt neurogenesis in a 
sufficiently significant way to have a demonstrable phenotype. However, it is possible 
that there is a transient alteration in neurogenesis that occurs soon after the initiation of 
follistatin induction that was missed by our detection methods. Furthermore, it is possible 
that the correct outcomes were not assessed. The primary outcome of interest was 
neurogenesis, leading to the analysis of neurons and proliferation. However, recent 
evidence suggests that in the presence of strong inhibition of the activin family, the most 
notable outcome was an increase in sustentacular cell production (Gokoffski, et al. 2011). 
In an effort to examine this question we assessed expression of Sox2 (a sustentacular cell 
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marker) in a subset of samples by QPCR and antibody staining, and did not observe any 
changes in Sox2 expression in the OE of mice exposed to high levels of follistatin. 
Finally, it is possible that no phenotype was observed because TGFβ signaling does not 
significantly contribute to the dynamics of neurogenesis and cellular homeostasis in the 
adult OE. In this case, it is curious that these molecules continue to be expressed through 
life. However, it is possible that the process of tissue maintenance is different and 
requires different signaling strategies than are utilized in the developing embryo. This 
possibility would corroborate the outcome of the next chapter in this thesis, both of which 
suggest that the cell types and signaling pathways utilized during embryogenesis may be 
distinct from those utilized in maintenance of the post-natal OE. 
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Figure 2.1 Approach to Conditionally Knock Down GDF11 in OE 
 
(A) Schematic representation of the wild type GDF11 allele (top), GDF11 flox allele, 
with loxP sites (gray triangles) inserted before exon 2 and after exon 3 (middle), and the 
GDF11 null allele (bottom), in which a neo cassette (white box) is inserted into exon 3, 
rendering the protein non-functional. The letters A-D indicate the position of primers 
used to genotype these mice. Primer sequences are: A: 5' 
AAGGCTTGGGAAGCAGGCAAG - 3', B: 5'- AGGTATGGTTAGGGTGTGGAG-3', 
C: 5'-AATGTCTGGGTGGGAGCCGTAAAC-3', D: 5'- 
TGGATGTGGAATGTGTGCGAGG-3'. PCR of A+B gives 359bp product in Wt or null 
allele, 393bp product in floxed allele. PCR of C+D gives 386bp product in null allele, no 
product in other alleles. 
 
(B) GDF11 RNA expression levels are unaltered by conditional knockdown strategy. 
Relative mRNA message level, as measured by real-time RT-PCR, demonstrate no 
difference between conditional knockdown mice (GDF11 flox/flox ; OMP-Cre ) (white 
bar) and  control mice (GDF11 flox/flox mice ; OMP +/+ ) (black bar). Values are 
corrected against GAPDH levels, and presented as mean +/- standard deviation. (n=2 for 
each group) 
 
(D) GDF11 expression pattern is unaltered by conditional knockdown strategy. There is 
no distinguishable difference in the pattern of expression between the control (GDF11 
flox/flox; OMP +/+) and conditional knockdown (GDF11 flox/flox ; OMP-Cre/+) mice. 
Sense probe control is shown. Scale bars = 10 µm. 
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Figure 2.2 Doxycyclin-induced expression is not observed in TRE-Myostatin ; 
cyp2g1-rtTA mice. 
 
(A) Schematic representation of  the genetic strategy utilized to induce myostatin 
expression in sustentacular cells. In sustentacular cells expressing the cyp2g1-rtTA gene, 
administration of doxycycline will lead to activation of the TRE promoter, driving 
expression of myostatin. 
 
(B) Schematic representation of a mouse OE. A sustentacular cell is highlighted in 
yellow, to depict the cell type that will be expressing myostatin. 
 
(C) Myostatin mRNA expression levels in whole OE are not increased after doxycycline 
induction. All mice were exposed to doxycycline for at least 30 days before sacrifice. 
Expression levels are unchanged in TRE-myostatin ; cyp2g1-rtTA mice compared to 
control (cyp2g1-rtTA mice). Expression levels in skeletal muscle are shown for 
comparison, which are 16 X higher than levels observed in OE. Values are corrected 
against GAPDH levels, and presented as mean +/- standard deviation. (n=4 for control 









































Figure 2.3 Robust Induction of Follistatin levels in OE 
 
(A) Schematic representation of the genetic strategy utilized to induce hFollistatin 
expression in sustentacular cells. In sustentacular cells expressing the cyp2g1-rtTA gene, 
administration of doxycycline will lead to activation of the TRE promoter, driving 
expression of hFollistatin. 
 
(B) Schematic representation of a mouse OE. A sustentacular cell is highlighted in 
yellow, to depict the cell type that will be expressing follistatin. 
 
(C) Follistatin levels are rapidly and robustly increased in mouse OE after doxycycline 
administration. By the third day of doxycycline administration, follistatin levels have 
risen to 50,000 X the leaky baseline levels. These levels rise another order of magnitude 
by day 30 of continuous doxycycline administration. Values depicted are mean (of 3 mice 
per time point) +/- standard deviation.  
 
(D) Comparison of follistatin levels to the highly expressed OMP transcript.  The 
expression level of follistain message is 10 fold higher than OMP levels by 30 days of 
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Figure 2.4 Follistatin induction is nonuniform 
(A) ISH on hemisection of mouse OE demonstrates that only a subset of sustentacular 
cells express the follistatin message. The distribution of follistatin-expressing cells does 
not appear to occur in a definitive pattern. Scale bar = 100 µm. 
 
(B) High power view of follistatin message expression pattern. As expected, the cells 
expressing the construct demonstrate the signature wine-glass morphology of 
sustentacular cells. Scale bar = 25 µm. 
 
(C) Follistatin protein is made in abundance by sustentacular cells. Anti-follistatin 
Antibody staining demonstrates labeling in a pattern that is similar to that seen by ISH. 







Figure 2.5 Neurogenesis is not altered by long-term follistatin production 
(A) Message levels of cells in the neuronal lineage are not affected by follistatin. RNA 
was harvested from the OE of adult TRE-follistatin ; cyp2g1-rtTA mice before (black 
bars) or after (gray bars) administration of doxycycline for 30 days.  Real time RT-PCR 
of OE did not demonstrate a difference in message levels of transit-amplifying neuronal 
precursors (Mash1), immediate neuronal precursors (Ngn1) or mature neurons (OMP). 
Values displayed as mean  (of 3 mice) +/- standard deviation.  
 
(B) Expression pattern of neuronal-lineage-specific messages is unchanged after long-
term doxycycline induction. TRE-FST ; cyp2g1-rtTA and control littermates (cyp2g1-
rtTA) mice were exposed to doxycycline for at least 30 days. ISH demonstrates that 
follistatin expression is robustly induced, but the pattern of expression of GAP43, 




















































Figure 2.6 Proliferation is unaltered after prolonged exposure to follistatin 
 
(A) BrdU incorporation is unaltered in TRE-FST ; cyp2g1-rtTA mice compared to 
littermate controls after 30 days of continuous administration of doxycycline. Scale bars 
= 10 µm. 
 
(B) Quantification of BrdU labeled cells in TRE-FST ; cyp2g1-rtTA mice compared to 











































There is limited capacity for the generation of neurons in the CNS of adult 
mammals, leading to significant mortality and morbidity in disease processes that result 
in central neuronal loss. The observation that a few areas of the adult CNS continually 
generate new neurons has provided hope that it may be possible to replace lost brain 
tissue. Understanding how these neurogenic regions are able to maintain this ability could 
lead to many therapeutic breakthroughs.  Of the three areas that continuously generate 
neurons that synapse in the brain throughout life, the OE is perhaps the simplest and most 
easily accessible. Given the relative ease with which this tissue may be harvested, and its 
prolific capacity to heal itself, the OE could prove to be a perfect reservoir of neurogenic 
stem cells.  
Although it is clear that the stem cell of the adult OE resides within the basal layer 
of that tissue, there is much debate over which of the two resident cell types is the true 
stem cell. Some researchers have toted the HBC as the true stem cell (Carter, et al. 2004; 
Mackay-Sim 2010). It is able to generate all other OE cell types both in vitro and in vivo, 
divides infrequently, and has demonstrated asymmetric cell division(Carter, et al. 2004; 
Leung, et al. 2007; Mackay-Sim and Kittel 1991a). In many respects, the properties of 
this cell resemble those of the presumed stem cells in the epidermis (Fuchs 2009). Others 
have suggested that the stem cell may reside within the population of GBCs, given their 




Until recently, much our understanding of the role of these two cell types has 
been inferred from either in vitro analysis of OE cell explants, transplantation studies of 
purified GBCs and HBCs, retroviral-labeling of OE cells, and colabeling studies of 
proliferating cells. While instructive, these methods suffer from either a lack of 
demonstrated relationship to regeneration in the native context (in vitro studies), or the 
potential for unnatural circumstances to influence the behavior of cells (transplantation). 
Further, colabeling studies would fail to capture the circumstances where a cell type 
down-regulates the protein used to label it before it can proliferate. This appears to be the 
case with HBCs, which are generally labeled with antibodies against keratin proteins, as 
these proteins are likely turned off before these cells reenter the cell cycle. A more 
definitive approach to ascertain the activity of a cell type can now be achieved through 
the use of cre-lox technology. Utilizing cre reporters that are specific for a given cell 
type, it is possible to irreversibly label a particular cell type and all of its subsequent 
progeny. Our lab previously utilized this strategy with a K5-creER construct to label 
HBCs (Leung, et al. 2007), demonstrating definitively that these cells have the capacity 
to serve as stem cells in response to chemical injury of the OE. However, these HBCs are 
rarely if ever activated during routine maintenance or in response to olfactory 
bulbectomy, where presumably activity of GBCs is sufficient to replace lost neurons. To 
further understand the role of GBCs in tissue maintenance and in response to bulbectomy, 
we utilized a similar labeling strategy to mark cells within the GBC population. 
Here we utilize a Mash1-labeling strategy to study the dynamics of these GBCs. 
We show that labeling in the early postnatal mouse leads to the production of 
predominantly neuronal cells, and that a subset of these cells become established in the 
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epithelium and persist for at least 3 months. By combining this labeling strategy with 
olfactory bulbectomy, we demonstrate that there does not appear to be a stem cell labeled 
by these Mash1-expressing cells, given the failure of expansion and neurogenesis in 
response to this lesion paradigm. By contrast, we demonstrate that labeling of these 
Mash1+ cells during embryogenesis leads to the production of multiple different cell 
lineages, including sustentacular cells and HBCs in addition to neurons. These data 






Experimental Animals and tamoxifen induction 
Mash1-CreER mice were produced by the collaborative efforts of our laboratory and the 
Jane Johnson laboratory. Details have been previously published (Kim, et al. 2011). 
Rosa-LacZ mice were purchased from Jackson Laboratory. K17-GFP mice were kindly 




Postnatal mice were injected with 2mg tamoxifen (1mg/100µL)  (Sigma, St. Louis, MO) 
per animal. Tamoxifen was weighed and dissolved fresh before each injection in 100% 
 48 
ethanol, then suspended 1:10 in sunflower seed oil to reach the final concentration 
(Sigma, St. Louis, MO) by vortexing for 1 minute. For embryonic injections, tamoxifen 
was dissolved as above, and injected at a concentration of 6mg/40g.  Given the difficulty 
of delivering after tamoxifen injection, fostering of pups was performed utilizing CD1 
dams who had recently given birth. Where specified, 4OHT was substituted for 
tamoxifen, being prepared and injected as previously described (Badea, et al. 2003). 
 
BrdU Injection and Tissue Preparation 
Where indicated, mice were injected intraperitoneally with 0.5 mg bromodeoxyuridine 
(brdU) (Sigma, St. Louis, MO) per 10g body weight 2 hours before sacrifice. Mice were 
deeply anesthetized with xylaket (Sigma, St. Louis, MO), and perfused with ice cold 4% 
PFA in PBS. Heads were prepared as previously described (Lewcock and Reed 2004), 
and post-fixed in 4%PFA for 30 min – overnight at 4 °C. Heads were switched to a 
solution of 30% sucrose, 250mM EDTA in PBS and incubated at 4 °C for 24hr – 72 hr. 
Heads were flash frozen in O.C.T. (Tissue-Tek, Torrance, CA) over dry ice or liquid 
nitrogen, and stored at -80 °C before sectioning. Tissue sections were cut at 8 – 20 µm 
and stored at -80 °C. 
 
Immunohistochemistry, X-gal staining, and microscopy 
Immunohistochemistry and X-gal staining were performed as previously described 
(Lewcock and Reed 2004), utilizing the following antibodies: rat anti-brdU (1:200, 
Abcam), anti GAP43 (1:500, Millipore), Anti O/E1 (1:1000, Connelly & Reed, 
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unpublished reagent).  Slides stained with anti-brdU were treated with 3N HCl for 30 min 
before incubation with primary antibody. Fluorescent visualization of primary antibody 
was accomplished utilizing the following secondary antibodies: Alexa-488 or Alexa-546-
conjugated species-specific IgG.  Nuclei were counterstained with 4',6-diamidino-2-




Unilateral bulbectomy was performed on mice deeply anesthetized with xylaket diluted 
1:10 in PBS at approximately 100µL/10g animal as described (Carr and Farbman 1992). 
Skull drilling was performed with a Northern Industrial Tools Mini Rotary Tool 
(NTE2100) equipped with a Dremel 107 engraving cutter bit. Stock Pasteur pipettes were 
used to remove olfactory bulb tissue with light vacuum suction. No packing was used to 
fill the empty cavity. 
 
Cell counting 
For each data point, the equivalent of a complete coronal section was counted for each 
mouse. This was either obtained by counting one complete coronal section, or 
hemisections from two different sections. Efforts were taken to count cells from similar 
areas of OE on the anteroposterior axis, judged by the amount of olfactory bulb present in 
each section. The total length of OE counted ranged from 9mm - 24mm. Data are 





Effective Labeling of GBCs in the neuronal lineage 
In the OE, Mash-1 has been demonstrated to be expressed in a transit amplifying 
population of cells that predominantly gives rise to neurons (Beites, et al. 2005). 
However, lineage tracing of Mash1+ cells in the embryo has demonstrated that they also 
give rise to sustentacular cells (Gokoffski, et al. 2011). The authors suggest from these 
observations that this subpopulation of Mash1-expressing cells may represent a lineage 
restricted “stem cell” due to its multipotency. However, it has not been demonstrated that 
the Mash1-expressing cells present in the postnatal mouse retain this multipotency. We 
utilized the same lineage-tracing paradigm to observe the behavior of Mash1-labeled 
cells in postnatal olfactory epithelium. This knock-in mouse expresses CreER from the 
endogenous Mash1 locus. Induction with tamoxifen provided the ability to mark these 
cells in a temporally-controlled fashion (Figure 3.1a-b). Activated CreER can lead to 
recombination at a reporter locus, marking the Mash1-expressing cell and all subsequent 
Mash1-negative progeny to express the marker protein. Previous work with this labeling 
construct has demonstrated a specific labeling of Mash1-expressing cells (Kim, et al. 
2007). Consistent with this study, we found that 3 days after tamoxifen injection of P7 
mice, the majority of labeled cells resided in the basal zone, defined as within one cell 
diameter of the basal lamina (Figure 3.1c,e). At 3 days, 61% of labeled cells were found 
within the basal layer. By comparison, by 3 weeks after injection, only 11% of labeled 
cells remain within the basal zone. Accordingly, when sections of OE from mice 
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sacrificed at early time points are stained for the immature neuronal marker GAP43, the 
tdtomato-labeled cells are found predominantly below the GAP43 layer. In contrast, the 
labeled cells tend to be intermingled with, or more apical to, the immature neurons when 
examined at 3 weeks (Figure 3.1 c, d). These data suggest that cells corresponding to 
GBCs are labeled, and that these labeled cells move apically and the majority progress 
along a path consistent with neuronal differentiation. Accordingly, when OE tissue from 
mice sacrificed 3 days after labeling is immunostained for the early differentiation marker 
O/E-1, many tdtomato-labeled cells are observed that already express this protein, and are 
elaborating dendritic processes characteristic of OSN differentiation (Figure 3.1 g-h). 
 
Mash1- labeled cells give rise to a subset of resident OE cells 
To determine whether Mash1-expressing cells in the postnatal OE retained stem-
like characteristics, we injected Mash1-CreER ; Rosa-tdtomato mice with a single 2mg 
dose of tamoxifen at age P7, and sacrificed at multiple time points from 3 days to 3 
months in order to examine the dynamics of the Mash1-labeled cells. If labeling was 
restricted to a transiently-amplifying population of cells, one would expect that after a 
few cell divisions, all labeled cells would develop into neurons. These neurons would be 
expected to sustain themselves in the OE for a normal lifespan, previously estimated at 
30-60 days. Further, one would expect a gradual decrease in the number of labeled cells 
over time. On the other hand, if a portion of the cells labeled had stem characteristics, we 
would expect to find evidence of multipotency, and the retention of cells with an 
undifferentiated, GBC phenotype. These cells might demonstrate active proliferation, 
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including the existence of clusters of expanding cells. We might also expect the quantity 
of labeled cells to remain constant, or even increase over time. 
We found that the density of labeled cells in Mash1-CreER ; Rosa-tdtomato mice 
injected with tamoxifen at P7 was greatest within the first few weeks of labeling, and that 
it steadily decreased over time. Figure 3.2a shows a coronal section of labeling frequency 
at 3 days after injection, which is much greater than the labeled cell numbers observed at 
2 months post-labeling (Figure 3.2b). Quantification of the labeled cell density shows an 
initial labeling density of 26.0 +/- 21.8 cells /mm OE (n=3 mice) when assessed 3 days 
after tamoxifen injection. The large standard deviation presumably reflects differences in 
labeling efficiency between mice. The labeling density remains high through 10 days 
(26.0 +/- 31.8 cells/mm OE (n=2)), but by 2 months, the density of labeled cells has 
decreased to 2.3 +/- 0.3 (n=2), and remains low at 3 months post labeling (3.5 +/- 0.5 
cells/mm OE (n=2)) (Figure 3.2c). This pattern of cell dynamics suggests that only a 
fraction of the labeled cells remain in the OE after several months. While the majority of 
the labeled cells (61%) are found in the basal zone at 3 days, by 10 days the basal 
compartment contains only 22% of the labeled cells. However, a similar fraction remains 
at 2 and 3 months, with the percentage of labeled cells found in the basal zone being 15% 
and 16% at these time points, respectively. However, this does not necessarily indicate 
that these cells in the basal zone are GBCs. In fact, dendritic processes can clearly be 
seen in many of these cells. One way to determine whether these remaining basal zone 
cells are GBCs that retain proliferative capacity or post-mitotic neurons would be to 
examine how they respond to lesion of the OE. 
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Mash1-labled Cells Perish in response to Bulbectomy 
Although it is widely accepted that Mash1-expressing cells are primarily a transient-
amplifying cell population that gives rise to neurons, it has been postulated that a subset 
of GBCs maintain stem cell character, and these cells are postulated to persistently 
express Mash1 (Gokoffski, et al. 2011). Additionally, it is known that robust 
neurogenesis takes place following olfactory bulbectomy, without activation of HBCs. It 
is believed that reconstitution of the epithelium under these conditions is mediated 
primarily by GBCs. To address this question, we performed unilateral olfactory 
bulbectomy one week after tamoxifen-induced OE labeling in Mash-creER ; Rosa-
tdtomato mice. If a subset of cells within the labeled population were stem cell competent 
for proliferation, we would expect that, following bulbectomy, there would be a clonal 
expansion of such a cell, giving rise to multiple neurons, and potentially other cell types. 
If only a transient-amplifying cell was labeled, we would expect that the resident, post-
mitotic labeled cells that had differentiated into neurons would be eliminated by 
bulbectomy. There does not appear to be any expansion of labeled cells at 5 or 10 days 
after lesion, and the labeled cells are essentially all eliminated by 30 days post-lesion 
(Figure 3.3). This is wholly consistent with the Mash1-CreER construct labeling cells 
demonstrating a transiently-amplifying behavior, without evidence of a stem cell 
population in this compartment. 
 
Mash1-labeled cells become restricted in their repertoire after birth 
GBCs have long been cited as a multipotent progenitor, as had been demonstrated in vitro 
and through transplantation experiments. However, there are few if any cells with 
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morphologies other than neuronal in the postnatally-labeled mice examined in the 
experiments reported here. Several explanations for this observation are possible. It could 
be that the specific labeling paradigm, using the Mash1-reporter, is not labeling the 
specific subtype of cells that demonstrate multipotency in published experiments. 
Alternatively, it is possible that the transplantation or culture conditions utilized in prior 
experiments were responsible for the observed behaviors. Specifically, the function of 
GBCs may have been altered by retroviral induction or transplantation. Additionally, 
recent experiments that demonstrated the potential of Mash1-labeled cells to give rise to 
sustentacular cells were performed at embryonic timepoints. To test whether differences 
may exist between the cell fates specified by Mash1-labeled cells pre-and postnatally, we 
injected pregnant Mash1-creER ; Rosa-tdtomato dams with tamoxifen at E12, a time 
when Mash1 expression is high in the developing mouse OE. We found that when 
labeled at this time, the cells clearly gave rise to sustentacular cells and HBCs in addition 
to neurons when examined at P14 (Figure 3.4). When these mice were crossed with a line 
expressing K17-GFP, cells were demonstrated that clearly expressed both reporter and 
GFP lining the basal lamina. These experiments definitively demonstrate for the first time 
that Mash1-labeled cells can give rise to cells with characteristics of HBCs.  
 Previous experiments in our laboratory demonstrated that HBCs remain quiescent 
during the neuronal turnover that takes place during olfactory bulbectomy in adult mice. 
Accordingly, examination of the OE 5 days after unilateral bulbectomy in a Mash-creER 
; Rosa-tdtomato mouse tamoxifen injected at E12 reveals that the HBCs which were 
labeled at E12 remain quiescent in the OE (Figure 3.5). These HBCs are the predominant 
tdtomato cell type that remains on the lesioned side. As with the P7-labled mice, there is 
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no evidence of clonal expansion of these labeled stem cells with HBC characteristics to 
repopulate the depleted OSNs.  
 
Discussion 
There exists considerable debate regarding which basal cell of the OE represents 
the tissue restricted “stem cell”. This debate is complicated by the correlation often made 
between the GBCs that are resident to the OE after birth, and the OPPs that proliferate 
during embryogenesis. Both of these cells types express Mash1. We utilized a lineage-
tracing approach to compare the characteristics of GBCs and OPPs. We found that, as has 
been suggested in published work, cells that express Mash1 in the postnatal mouse 
behave like a transient amplifying cell. We found that within a few weeks of labeling 
there was a net loss of labeled cells in the tissue. Of course, caution should be maintained 
when interpreting quantitative comparisons across animals, especially considering the 
variability in labeling efficiency possible in these experiments. However, the trend 
toward a reduction of cells over time is clear and corroborates previous observations that 
the proliferative progenitors in the OE produce more cells than will eventually become 
stably incorporated into the tissue, with a considerable number of the neurons produced 
failing to make functional, stable connection to the olfactory bulb.  
Despite the overall loss of cells over time, there were cells that remained in the 
OE for several months. That the majority of these cells reside in the neuronal zone and 
demonstrate neuronal morphology provides further evidence that, at least in purified air 
environments, olfactory neurons can have life spans that significantly exceed one month. 
Indeed, our observation that there is a dramatic reduction of labeled cells by one month 
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are also consistent with the observations that led to the frequently stated “one month” 
span of neurons. However, we also detected cells that resided within the basal zone at 
several months after labeling. Given that cells were observed that were adjacent to the 
basal lamina but were projecting axons and dendrites, it is likely that these cells were 
merely neurons occupying a basal position in the OE. However, it is possible that these 
are in fact cells that retain stem character. If this is the case, it is surprising that there was 
no proliferation, or even a quiescent persistence, of these cells in response to olfactory 
bulbectomy, a precedure that selectively kills mature neurons in the OE while sparing 
other cell types. That there was no clonal expansion or persistence observed in these cells 
makes it unlikely that they represent a cell with stem characteristics. 
 One of the confounding factors in the interpretation of labeling density in this 
work is the fact that we are studying young mice, in which the OE is still growing and 
expanding. This will naturally lead to a dilution of labeled cell density over time. It 
would be advantageous to label cells in older mice, when the OE is fully developed and 
this is no longer a consideration. However, it is difficult to adequately label cells utilizing 
the Mash1-CreER construct when injected later in life. This presumably reflects the 
lower abundance of target cells, increased metabolism of the tamoxifen in the target 
tissue and perhaps reduced targeting to the genomic locus. At the concentrations used in 
these experiments, we saw no labeling in mice labeled later than P21. 
A final consideration in our experiments is that we may be labeling a specific 
fraction of the Mash1-expressing cells in the epithelium. For example, poor labeling 
efficiency may select for cells that are highly-expressing the Mash1-promoter. Such cells 
would be more likely to proceed along the pathway of neurogenesis, which may bias the 
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results toward neuronal fates among Mash1-labeled progeny. This seems unlikely given 
that labeling density was no greater in the embryo than in postnatal mice, and yet 
multipotency was observed in the embryonically-labeled mice. Another consideration is 
that the Mash1-CreER utilized is knocked into the endogenous locus. There does not 
appear to be any effects from only having a single copy of the Mash1 gene, but given that 
Mash1 knock out mice preferentially produce sustentacular cells at the expense of 
neurons, any reduced expression of Mash1 in our model system should in fact increase 
the probability that the reporter-labeled cells would proceed down a sustentacular 
differentiation pathway. 
 The studies reported here provide important new insights into the dynamics of 
olfactory epithelium regeneration and regulation. Specifically, a new Mash1-expressing 
cell type in the embryonic OE appears to give rise to two population of cells in the post-
embryonic epithelium.  A fraction of these cells are characteristic of the previously 
recognized Mash1-expressing GBCs while a subset of the embryonically-labeled cells 
subsequently reside in a position and express markers associated with highly quiescent 
HBCs.  Taken together, these observations further provide the basis for a new model to 
explain the role of Mash1-labeled cell fates between the embryonically-labeled OPPs and 




Figure 3.1. Effective Labeling of Mash1+ Cells in Mouse OE 
 
(A) Schematic of the genetic construct utilized to irreversibly label Mash1-expessing 
cells. CreERT2 is expressed from the endogenous Mash1 locus.  Induction with 
tamoxifen leads to nuclear translocation of CreERT2, which can activate transcription of 
reporter protein message by splicing out the preceding “stop” sequence. (B) Schematic of 
the OE demonstrating the selective labeling of a subset of GBCs. This is the cell type 
targeted for initial labeling in Mash1-CreERT2 ; Rosa-tdtomato mice after tamoxifen 
induction. (C) Representative OE section of Mash1-CreER ; Rosa-tdtomato mouse 3 days 
after tamoxifen induction. The majority of tdtomato-labeled cells are found within the 
basal compartment, below the GAP43-immunostained immature neurons. (D) Reporter-
labeled cells reside predominantly in the neuronal layer by 3 weeks after labeling. 
Representative image of OE section demonstrating reporter-labeled cells residing above 
the GAP43-immunostained immature neuronal layer. A dendritic process is clearly 
visible protruding from one of the labeled cells. (E) Quantification of cells found within 
the basal zone (within one cell diameter of the basal lamina) or neuronal layer (all cells 
found above the basal layer but below the sustentacular layer). 3 days after tamoxifen 
induction, the labeled cells are predominantly found in the basal compartment (n=2, mean 
+/- standard deviation). (F) Quantification of basal and apical position of cells 3 weeks 
after labeling.  Labeled cells have migrated from the basal compartment to the neuronal 
compartment (n=2, mean +/- standard deviation). (G-H) A subset of reporter-labeled cells 
express O/E1 3 days after labeling.  High power images of two confocal planes through 
the same area of tissue are shown. Tissue is immunostained with anti-O/E1 antibody 
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(green). Arrows and arrowheads provide visual cues to identify labeled cells visualized in 














































































Figure 3.2  Reporter-labeled cells persist in the OE 
 
(A-B) Representative hemisections of mice sacrificed 3 days (A) or 2 months (B) after 
tamoxifen labeling at P7. There is a clear decrease in the number of cells present at 3 
months. No clustering of cells is noted in the 3 month chase, indicating that labeled cells 
do not continue to expand.  To improve visualization, images were desaturated and color 
inverted using Adobe Photoshop software. Scale bars = 50 µm. (C) Density of labeling 
decreases within weeks of tamoxifen labeling. Mash1-CreER ; Rosa-tdtomato mice 
labeled at P7 were sacrificed at multiple timepoints through 3 months. The density of 
reporter + cells counted in OE sections is shown. Though the number of labeled cells 
decreases over time, a significant number of labeled cells persist through 3 months. (D) 
The proportion of labeled cells found within the basal layer decreases rapidly then 
stabilizes. The number of cells residing in the basal (black bars) and neuronal (white 
bars) layers were added for all mice in each chase category, and are presented as the 


























































Figure 3.3 Olfactory Bulbectomy Depletes the OE of Reporter-Labeled Cells 
 
Reporter-labeled cells are greatly diminished on the lesioned side 30 days after 
bulbectomy. (A) DAPI-stained coronal section of Mash1-CreER ; Rosa-tdtomato mouse 
sacrificed 30 days after bulbectomy. Only a few reporter-labeled cells remain in the OE 
on the lesioned side. High-power views of the unlesioned (C) and lesioned (D) are 
shown. (B) Comparison of reporter-labeled cell density of two hemisections after 
olfactory bulbectomy. The number of cells labeled in the OE of the lesioned side (filled 
diamonds) decreases dramatically by 30 days compared to the unlesioned side (open 












































Figure 3.4 Repertoire of differentiation in Mash1+ cells is restricted after birth 
 
Representative OE Sections from Mash-CreER ; Rosa-tdtomato ; K17-GFP mice 
tamoxifen injected at either P7 (A-B) or E12 (C-D) and sacrificed 3 weeks later. 
Reporter-labeled cells from the P7-injected mice are exclusively round cells in the 
neuronal layer, many with visible dendritic processes (A-B). Clusters of cells 
demonstrating a distinct sustentacular morphology are found only in the E12-injected 
mice (C). HBCs labeled with both K17-GFP and tdtomato are also found exclusively in 
the E12-injected mice (D). Red = intrinsic tdtomato fluorescence, Green = intrinsic EGFP 
fluorescence. Scale bars = 20 µm. 
  








Figure 3.5 Reporter-labeled HBCs persist after Olfactory Bulbectomy 
 
Coronal section of an E12 tamoxifen-induced Mash1-CreER ; Rosa-tdtomato mouse, 
bulbectomized at P14 and sacrificed 5 days later. There is a dramatic reduction of cell 
labeling on the lesioned side (A). High-powered view of the unlesioned side (B) 
demonstrates labeling of both neurons and HBCs, whereas on the lesioned side, the few 










The continual neuroregeneration that takes place in the mammalian OE 
throughout the life of the animal provides a system with great therapeutic potential. How 
this tissue maintains this capacity is poorly understood. One hypothesis is that similar 
mechanisms that are employed during the embryogenic creation of the OE remain active 
in the adult. The experiments described in this dissertation provide evidence that this may 
not be the case. First, no role in controlling adult neurogenesis was found for TGFβ 
signaling, an important embryonic regulator. Second, labeling of Mash1-expressing cells 
demonstrated that this transcription factor appears to label a distinct population of 
multipotent progenitors in the embryo not seen in postnatally-labeled mice. These 
findings have important clinical implications. 
Several psychiatric and neurological diseases have been hypothesized to result 
from defects in brain development. Brain development occurs in various stages, and 
continues into adulthood. That fundamental differences exist in the regulation of OE 
neurogenesis between the embryonic and postnatal period highlights the importance of 
studying neurodevelopment at all its various stages, as mechanisms discovered during 
one stage may not be generalizable. That alternative regulator pathways may be involved 
at different stages also suggests that defects in neurodevelopment may occur in the 
postnatal animal after a normal embryonic development, which broadens the window of 
therapeutic intervention. 
Furthermore, the experiments described provide important insights into the 
challenges that exist in harnessing the neurogenic potential of the OE. Given its anatomic 
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accessibility, the OE may provide an ideal location for harvesting neural stem cells for 
therapeutic applications. Understanding the nature of these stem cells is an important first 
step in actualizing this goal. It is equally important to identify unique molecular 
signatures on these stem cells to allow proper isolation and purification. Mash1 is a 
marker that labels a subset of GBCs that has been utilized for this purpose. These data 
suggest that Mash1 may not be a suitable candidate for isolating a multipotent and 
continually-proliferating progenitor from adult OE. Further work is needed to determine 
whether there exists a subset of GBCs that retain this capacity, and if so, a suitable 
molecular marker to identify them. However, it is possible that this stem cell capacity is 
limited to HBCs, and efforts to isolate and study this important stem cell population may 
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